104 related articles for article (PubMed ID: 699349)
1. Tissue growth hormone release inhibiting hormone-like immunoreactivity in experimental hypothyroidism and hypopituitarism.
Berelowitz M; Pimstone B; Shapiro B; Kronheim S; De Wit D
Clin Endocrinol (Oxf); 1978 Aug; 9(2):185-91. PubMed ID: 699349
[TBL] [Abstract][Full Text] [Related]
2. The characterization of growth hormone release inhibiting hormone-like immunoreactivity in normal urine.
Kronheim S; Berelowitz M; Pimstone BL
Clin Endocrinol (Oxf); 1977 Oct; 7(4):343-7. PubMed ID: 923109
[TBL] [Abstract][Full Text] [Related]
3. Tissue and serum somatostatin-like immunoreactivity in fed, 15-h-fasted, and 72-h-fasted rats.
Shapiro B; Berelowitz M; Pimstone BL; Kronheim S; Sheppard M
Diabetes; 1979 Mar; 28(3):182-4. PubMed ID: 446903
[TBL] [Abstract][Full Text] [Related]
4. The effect of hypophysectomy on pancreatic islet hormone and insulin-like growth factor I content and mRNA expression in rat.
Jevdjovic T; Maake C; Zwimpfer C; Krey G; Eppler E; Zapf J; Reinecke M
Histochem Cell Biol; 2005 Feb; 123(2):179-88. PubMed ID: 15812646
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoassay for GH-release inhibiting hormone.
Arimura A; Sato H; Coy DH; Schally AV
Proc Soc Exp Biol Med; 1975 Mar; 148(3):784-9. PubMed ID: 1129301
[TBL] [Abstract][Full Text] [Related]
6. Role of the hypophysis in regulation of pancreatic and gastric somatostatin.
Recant L; Voyles NR; Wilkins SD; Fairtile RD; King C
Endocrinology; 1984 Dec; 115(6):2260-5. PubMed ID: 6149930
[TBL] [Abstract][Full Text] [Related]
7. Effects of growth hormone excess and deficiency on hypothalamic somatostatin content and release and on tissue somatostatin distribution.
Berelowitz M; Firestone SL; Frohman LA
Endocrinology; 1981 Sep; 109(3):714-9. PubMed ID: 6114854
[TBL] [Abstract][Full Text] [Related]
8. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics.
Waldhäusl W; Bratusch-Marrain P; Dudczak R; Deutsch E
J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515
[TBL] [Abstract][Full Text] [Related]
9. Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin.
Konturek SJ; Tasler J; Cieszkowski M; Coy DH; Schally AV
Gastroenterology; 1976 May; 70(5 PT.1):737-41. PubMed ID: 1261766
[TBL] [Abstract][Full Text] [Related]
10. The effect of hypophysectomy on somatostatin-like immunoreactivity in discrete hypothalamic and extrahypothalamic nuclei.
Terry LC; Crowley WR
Endocrinology; 1980 Dec; 107(6):1771-5. PubMed ID: 6107243
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone release inhibiting hormone: actions on thyrotrophin and prolactin secretion after thyrotrophinreleasing hormone.
Carr D; Gomez-Pan A; Weightman DR; Roy VC; Hall R; Besser GM; Thorner MO; McNeilly AS; Schally AV; Kastin AJ; Coy DH
Br Med J; 1975 Jul; 3(5975):67-9. PubMed ID: 806323
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone-release inhibiting hormone (GH-RIH) pathway of the rat hypothalamus revealed by the unlabeled antibody peroxidase-antiperoxidase method.
King JC; Gerall AA; Fishback JB; Elkind KE
Cell Tissue Res; 1975 Jul; 160(4):423-30. PubMed ID: 1149126
[TBL] [Abstract][Full Text] [Related]
13. Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion.
Konturek SJ; Tasler J; Obtulowicz W; Coy DH; Schally AV
J Clin Invest; 1976 Jul; 58(1):1-6. PubMed ID: 932201
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.
Berelowitz M; Kronheim S; Pimstone B; Shapiro B
J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602
[TBL] [Abstract][Full Text] [Related]
15. Modulation of brain insulin-like growth factor I (IGF-I) binding sites and hypothalamic GHRH and somatostatin levels by exogenous growth hormone and IGF-I in juvenile rats.
Eshet R; Gil-Ad I; Apelboym O; Segev Y; Phillip M; Werner H
J Mol Neurosci; 2004; 22(3):179-88. PubMed ID: 14997011
[TBL] [Abstract][Full Text] [Related]
16. Tissue and serum somatostatin-like immunoreactivity in lean and obese Zucker rats.
Sheppard MC; Shapiro B; Hudson A; Pimstone BL
Horm Metab Res; 1980; 12(6):236-9. PubMed ID: 6105993
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) immunoreactivity in the rodent and primate CNS: distribution, characterization and presence posthypophysectomy.
Hojvat S; Baker G; Kirsteins L; Lawrence AM
Brain Res; 1982 May; 239(2):543-57. PubMed ID: 7093701
[TBL] [Abstract][Full Text] [Related]
18. Increase by somatostatin of the arginine induced rise in blood glucose in untreated insulin requiring diabetics.
Waldhäusl W; Bratusch-Marrain P; Nowotny P
Endokrinologie; 1979; 73(3):323-7. PubMed ID: 499100
[TBL] [Abstract][Full Text] [Related]
19. Intraventricularly injected growth hormone stimulates somatostatin release into rat hypophysial portal blood.
Chihara K; Minamitani N; Kaji H; Arimura A; Fujita T
Endocrinology; 1981 Dec; 109(6):2279-81. PubMed ID: 6118262
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by somatostatin (growth-hormone release-inhibiting hormone, GH-RIH) of gastric acid and pepsin and G-cell release of gastrin.
Barros D'sa AA; Bloom SR; Baron JH
Gut; 1978 Apr; 19(4):315-20. PubMed ID: 348581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
